Login
$LFCR
$6.52 +$0.01 (0.15%) Close

$LFCR SEC Filings

Filed On Filing
20 Oct 2026 8-K: Other Events

As previously disclosed, on September 27, 2026, Lifecore Biomedical, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Lifecore Inc. and Hazel Merger Sub, Inc.

29 Sep 2026 SCHEDULE 13D/A
29 Sep 2026 8-K: Entry into a Material Definitive Agreement

On September 24, 2026, Lifecore Biomedical, LLC (“Lifecore”), a subsidiary of Lifecore Biomedical, Inc. (the “Company”), entered into an Amendment No. 3 to Amended and Restated Contract Manufacturing Agreement (the “Third Amendment”) wit...

28 Sep 2026 SCHEDULE 13D/A
28 Sep 2026 DEFA 14A
28 Sep 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Exhibit B – Certificate of Incorporation of the Surviving Corporation

05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
29 Jul 2026 SCHEDULE 13G
02 Jul 2026 SCHEDULE 13D/A
02 Jul 2026 SCHEDULE 13D/A
02 Jul 2026 8-K: Regulation FD Disclosure
08 Jun 2026 Form 4: Kiper Christopher S, Director and 6 others

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Aryeh Jason, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Schechter Joshua, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Korenberg Matthew E, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Antunes Humberto Calheiros, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Johnson Paul Harold, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Houde Lovas Katrina, Director

Received 25,907 shares as a grant or award

05 Jun 2026 Form 4: Obus Nelson, Director

Received 25,907 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support